This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Point-of-care Molecular Diagnostics Market

Point-of-care Molecular Diagnostics Market by Product & Service, Technology, Application & Region - Forecast 2022 - 2032

Market Insights on Point-of-care Molecular Diagnostics covering sales outlook, demand forecast & up-to-date key trends

Point-of-Care Molecular Diagnostics Market Outlook (2022-2032)

[321 Pages Report] The global point-of-care molecular diagnostics market size was estimated to be worth US$ 3 Bn in 2021 and is forecast to grow at a robust CAGR of 8% during the assessment period from 2022 and 2032, reaching around US$ 11 Bn by 2032. Rising prevalence of infectious diseases and cancer worldwide and growing end user preference for point of care molecular testing due to its attractive features are the major forces behind the expansion of point-of-care molecular diagnostics market.

Market Outlook:

Data Points

Market Insights

Point-of-Care Molecular Diagnostics Market Value 2021

USD 3 Bn

Point-of-Care Molecular Diagnostics Market Value 2032

USD 11 Bn

Point-of-Care Molecular Diagnostics Market Forecast CAGR 2022-2032

 8%

Point-of-care Molecular Diagnostics Market Attraction

Breakthroughs in proteomics and molecular methods to bring improvements

Key Players

Abbott Laboratories (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), bioMérieux S.A. (France), Danaher Corporation (U.S.), Quidel Corporation (U.S.), QIAGEN N.V. (Netherlands), Co-Diagnostics, Inc. Biocartis NV (Belgium), Meridian Bioscience, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.)

Molecular diagnostics has been used by medical professionals in laboratories and other healthcare settings for a long time. However, various drawbacks such as high cost of tests, time consuming nature and delay in results of molecular diagnostics has prompted them to look for better diagnostic solutions. This has brought point-of-care molecular diagnostic market into the spotlight.

Point-of-care molecular diagnostics has gained a lot of traction across end use verticals including hospitals and research institutions due to its ability to reduce turnaround time and provide rapid and accurate results. Point of care molecular testing allows the rapid and early detection of diseases in non-laboratory settings. These tests are usually performed at nearby patients' locations.

Rising adoption of point of care molecular diagnostic solutions for the early detection of a wide range of diseases ranging from respiratory diseases and cancer to sexually transmitted diseases and gastrointestinal disorders is a key factor driving the growth in point-of-care molecular diagnostics market.

Similarly, rapid growth in molecular diagnostics market and molecular imaging market supported by growing health awareness among people across emerging economies will create opportunities for point of care molecular diagnostics manufacturers during the forthcoming years.

Furthermore, recent advancements in microfluidics and genetic sequencing coupled with development of low-cost and rapid point-of-care molecular diagnostic platforms will boost sales of POC molecular diagnostics products, thereby expanding the molecular POC tests market size.

Customize this Report

Let us know your requirement to get
100% FREE customization

Point-of-Care Molecular Diagnostics Demand Analysis (2015-2021) Compared to Market Forecasts (2022-2032)

The global demand for point-of-care molecular diagnostics is anticipated to grow at a healthy CAGR of around 8% during the forecast period between 2022 and 2032. Rising prevalence of chronic and infectious diseases, increased focus on decentralized diagnostics, bourgeoning spending in research and development activities worldwide, growing need for early detection of infectious diseases, and faster development and commercialization of advanced technologies are some of the major factors expected to drive growth in the global point-of-care molecular diagnostics market.

Besides this, improved therapeutic and diagnostic alternatives, such as personalized medicine and biomarker identification along with breakthroughs in proteomics and molecular methods and surge in adoption of point of care molecular PCR is expected to further boost the sales of POC molecular diagnostic products during the forecast period.

Point of care molecular diagnostic testing has become a highly sought-after method for analyzing and identifying the biological markers in the genome and proteome in order to identify gene expression by applying molecular biology. It allows physicians to improve the standard of care by combining the ability to quickly make a diagnosis and treatment decision during the patient’s initial visit rather than having to wait for hours.

Increasing incidence of infectious disease and cancer is providing a major impetus to the growth of point of care molecular diagnostics market and the trend is likely to escalate during the forecast period. According to the American Cancer Society, an estimated 1.9 million new cancer cases and 609,360 deaths from cancer are expected to occur in the US during 2022.

Similarly, increasing public-private funding in research and development coupled with advancement in personalized medicine and growing popularity of POC molecular diagnostics in preventive healthcare will generate sales prospects for POC molecular diagnostic products in the future.

Which Factors are Restraining the Growth of Point-of-Care Molecular Diagnostics Market?

Despite a positive outlook, the global point-of-care molecular diagnostics market is facing various challenges that are likely to restrict its growth during the forecast period. Some of these factors are the absence of proper reimbursement policies, lack of awareness across developing regions, and poor penetration of advanced point-of-care molecular diagnostic devices in some regions.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Country-Wise Insights

How Will Growth Unfold in the U.S Point of Care Molecular Diagnostics Market?

According to the Future Market Insights, the U.S. point-of-care molecular diagnostics market is forecast to grow at a healthy CAGR over the forecast period, owing to the increased research operations for the development of novel products, presence of leading market players, rise in cases of cancer and several infectious diseases, favorable government support, and rapid expansion of automated molecular diagnostics testing system market.

The North American point-of-care molecular diagnostics market which was worth more than US$ 1.4 billion in 2020 was mostly dominated by the U.S. and the trend shows that this will continue to prevail during the forecast period as well.

Most of the end users across the United States are showing a keen inclination towards employing POC tests for safe and early diagnosis of infectious diseases. Similarly, increasing spending in research and development for introducing advanced POC molecular diagnostic tests will create sales prospects for point-of-care molecular diagnostic platforms in future.

Furthermore, increasing usage of point of care molecular PCR, commercialization of real-time PCR products, and growing popularity of point of care molecular covid test will assist market growth in the region.

Why is Demand for Point-of-Care Molecular Diagnostics Rising Across the U.K.?

The U.K point-of-care molecular diagnostics market is poised to exhibit strong growth during the forecast period owing to the presence of a highly established healthcare industry, rapid growth of molecular diagnostics market, increasing investments by government and non-government organizations in research and development, and growing adoption of point of care molecular PCR across end use verticals.

Similarly, rise in cases of infectious diseases, gastrointestinal disorders, and cancers is spurring the POC molecular diagnostics sales in the region. According to Cancer Research UK, there were around 375400 new cases of cancer in the U.K between 2016 and 2018.

Category-Wise Insights

Which Product & Service Segment Leads the Point-of-Care Molecular Diagnostics Market?

“Assays & Kits to Remain High in Demand Across End Use Verticals”

By product & service, assays & kits segment dominated the global point-of-care molecular diagnostics market in 2021 and is projected to grow at a robust pace during the assessment period. Rising adoption of these products across major end use verticals is triggering the growth of this segment.

Similarly, growing popularity of point of care molecular testing due to its highly accurate and quicker nature will continue to fuel the demand for assays & kits during the forecast period.

Which is the Most Lucrative Application for Point-of-Care Molecular Diagnostics?

“Surge in Respiratory Diseases to Boost Sales of POC Molecular Diagnostic Products”

Based on application, the respiratory diseases segment is expected to remain the most lucrative application area for point-of-care molecular diagnostics. This is attributable to the rising prevalence of respiratory diseases worldwide and advancements in infectious illness POC molecular testing.

For instance, according to a report published in The LANCET, there were around 17.2 billion cases of upper respiratory infections (URIs) globally in 2019. This will continue to expand the POC tests market size and help molecular diagnostics manufacturers to increase their sales.

Which Technology Segment Contributed the Most in Point-of-Care Molecular Diagnostics Market?

“RT-PCR to Remain the Most Preferred Technology in the Global Point-of-Care Molecular Diagnostics Market”

As per FMI, RT-PCR segment accounted for the largest revenue share in the global point-of-care molecular diagnostics market in 2021 and is forecast to further grow at a healthy pace. Increasing usage of RT-PCR in proteomics, genomics, and COVID-19 testing, availability of portable and easy-to-use instruments, and growing end user preference for RT-PCR due to its various benefits including high sensitivity and specificity, cost effectiveness, and less time-consuming nature are some of the factors triggering the segment growth.

Furthermore, expansion of RT-PCR kits market across the world is likely to favor the growth of this segment during the upcoming years.

Which End User Segment Leads the Point-of-Care Molecular Diagnostics Market?

“Hospitals & ICUs Remain Ideal Destinations for Point-of-Care Molecular Testing”

Based on end users, hospitals & ICUs segment accounts for the largest revenue share of the point-of-care molecular diagnostics market. Rise in the number of hospitals coupled with increasing adoption of point of care molecular testing in hospitals and ICUs for fast and accurate detection of diseases is favoring growth of this segment.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Competitive Landscape

Key POC molecular diagnostic manufacturers operating in the market include Abbott Laboratories (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), bioMérieux S.A. (France), Danaher Corporation (U.S.), Quidel Corporation (U.S.), QIAGEN N.V. (Netherlands), Co-Diagnostics, Inc. Biocartis NV (Belgium), Meridian Bioscience, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.). These players are constantly focusing on developing innovative point-of-care molecular diagnostic platforms such as point-of-care molecular COVID test and paper-based nucleic acid amplification tests, and that can effectively detect diseases with ease. Furthermore, they have adopted strategies like mergers, acquisitions, partnerships etc. to expand their global footprint.

  • In March 2020, Abbott Laboratories ID NOW point-of-care test for the detection of coronavirus.
  • In July 2021, QuantuMDx launched Q-POC™, a rapid, PCR point of care diagnostic system.
  • In 2022, Co-Diagnostics, a molecular diagnostics company completed the acquisition of Idaho Molecular and Advanced Conceptions.

Point-of-Care Molecular Diagnostics Market Report Scope

With the aim of providing a complete and detailed industry analysis, FMI’s latest report on the point-of-care molecular diagnostics market digs deep into key drivers, prevailing trends and emerging opportunities affecting the market dynamics. It uncovers key investment pockets within the point-of-care molecular diagnostics market and explains how prominent molecular diagnostics manufactures are innovating to meet end user demands.

Through a systemic approach, the report provides solutions to queries like how advancement in molecular diagnostic technology is influencing the POC molecular diagnostics sales? Why is North America becoming an attractive destination for point-of-care molecular diagnostic devices? And how will expansion of molecular diagnostics market create growth prospects for the manufacturers of point-of-care molecular diagnostics platforms?

FMI also attempts to provide insights into factors pushing sales of point-of-care molecular diagnostics products across developed and developing regions. The report further dedicates certain chapters to analyzing leading segments along with their market shares.

Want to get a comprehensive assessment of point-of-care molecular diagnostic market and understand the futuristic growth projections? Keep in touch with one of the leading research companies of the world “Future Market Insights”.

The Point-of-Care Molecular Diagnostics market analysis includes:

  • A 10-year realistic point-of-care molecular diagnostics sales forecast across multiple verticals
  • Comprehensive information on demand forecasting and sales prospects across 25 countries
  • Impact of novel infectious diseases including COVID-19 on the sales of POC molecular diagnostics products
  • Detailed analysis of regional pockets along with degree of market penetration
  • Information about emerging end user demands
  • Key insights into leading market and product segments along with their respective shares, growth forecast and market potential
  • Top POC molecular diagnostic manufacturers in the market, and key competitive factors
  • An in-depth analysis of growth strategies adopted by top players to penetrate attractive markets
  • Knowledge about the key challenges and winning imperatives in this Market
  • Market dynamics including drivers, restraints and emerging trends

Attribute

Details

Forecast Period

2022-2032

Historic Data Available for

2015-2021

Market Analysis

USD Million for Value

Report Coverage

Market forecast, company share analysis, competition intelligence, DROT analysis, market dynamics and challenges, and strategic growth initiatives

Key Segments Covered

  • Product & Service
  • Technology
  • Application
  • End User
  • Region

Key regions covered

North America

  • US
  • Canada
  • Rest of North America

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Western Europe

  • Germany
  • U.K.
  • France
  • Rest of Western Europe

Eastern Europe

  • Russia
  • Spain
  • Rest of Eastern Europe

South Asia Pacific

  • China
  • India
  • Japan
  • Malaysia
  • Thailand
  • Indonesia
  • South Korea
  • Rest of South Asia & Pacific

Middle East & Africa

  • GCC Countries
  • Turkey
  • Israel
  • Rest of MEA

Rest of the World

  • Oceania
  • Africa
  • South America

End User

  • Physicians’ Offices
  • Hospitals & ICUs
  • Research Institutes
  • Other End Users

Key companies profiled

Abbott Laboratories (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), bioMérieux S.A. (France), Danaher Corporation (U.S.), Quidel Corporation (U.S.), QIAGEN N.V. (Netherlands), Co-Diagnostics, Inc. Biocartis NV (Belgium), Meridian Bioscience, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.)

Customization & pricing

Available upon request

Point-of-Care Molecular Diagnostics Market Key Segments

By Product & Service:

  • Assays & kits
  • Instruments & Analyzers
  • Software & Services

By Technology:

  • RT-PCR
  • INAAT
  • Other technologies

By Application:

  • Respiratory Diseases
  • Sexually Transmitted Diseases
  • Hospital-acquired Infections
  • Cancer
  • Hepatitis
  • Gastrointestinal Disorders
  • Other Applications

By End User:

  • Physicians’ Offices
  • Hospitals & ICUs
  • Research Institutes
  • Other End Users

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Frequently Asked Questions

The global point-of-care molecular diagnostics market size was estimated to be worth around US$ 3 Bn in 2021.

As per FMI, point-of-care molecular diagnostics market is expected to grow at 8% CAGR during the forecast period, reaching around US$ 11 Bn by 2032.

North American remains the most dominating market for point-of-care molecular diagnostics.

The assays and kits segment accounts for the largest share of the point-of-care molecular diagnostics market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook 

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. FMI Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage 

    2.2. Market Definition 

3. Market Risks and Trends Assessment 

    3.1. Risk Assessment 

        3.1.1. COVID-19 Crisis and Impact on Point of Care Molecular Diagnostics

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis 

        3.1.3. Impact on Market Value (US$ Bn)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background 

    4.1. Point of Care Molecular Diagnostics Market, by Key Countries

    4.2. Point of Care Molecular Diagnostics Market Opportunity Assessment (US$ Bn)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast 

        4.3.1. Demand in optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario 

    4.4. Investment Feasibility Analysis

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors - Relevance & Impact

        4.5.1. Top Companies Historical Growth

        4.5.2. Growth in Automation, By Country

        4.5.3. Point of Care Molecular Diagnostics Adoption Rate, By Country

    4.6. Market Dynamics

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. Point of Care Molecular Diagnostics Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors 

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking 

6. Global Point of Care Molecular Diagnostics Market Demand Analysis 2015-2021 and Forecast, 2022-2032

    6.1. Historical Market Analysis, 2015-2021

    6.2. Current and Future Market Projections, 2022-2032

    6.3. Y-o-Y Growth Trend Analysis

7. Global Point of Care Molecular Diagnostics Market Value Analysis 2015-2021 and Forecast, 2022-2032

    7.1. Historical Market Value (US$ Bn) Analysis, 2015-2021

    7.2. Current and Future Market Value (US$ Bn) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Point of Care Molecular Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Product & Service

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Bn) Analysis By Product & Service, 2015-2021

    8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Product & Service, 2022-2032

        8.3.1. Assays & kits

        8.3.2. Instruments & Analyzers

        8.3.3. Software & Services

    8.4. Market Attractiveness Analysis By Product & Service

9. Global Point of Care Molecular Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Technology

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Bn) Analysis By Technology, 2015-2021

    9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Technology, 2022-2032

        9.3.1. RT-PCR

        9.3.2. INAAT

        9.3.3. Other technologies

    9.4. Market Attractiveness Analysis By Technology

10. Global Point of Care Molecular Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Application

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Bn) Analysis By Application, 2015-2021

    10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Application, 2022-2032

        10.3.1. Respiratory Diseases

        10.3.2. Sexually Transmitted Diseases

        10.3.3. Hospital-acquired Infections

        10.3.4. Cancer

        10.3.5. Hepatitis

        10.3.6. Gastrointestinal Disorders

        10.3.7. Other Applications

    10.4. Market Attractiveness Analysis By Application

11. Global Point of Care Molecular Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By End User

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Bn) Analysis By End User, 2015-2021

    11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2022-2032

        11.3.1. Physicians’ Offices

        11.3.2. Hospitals & ICUs

        11.3.3. Research Institutes

        11.3.4. Other End Users

    11.4. Market Attractiveness Analysis By End User

12. Global Point of Care Molecular Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Region

    12.1. Introduction

    12.2. Historical Market Size (US$ Bn) Analysis By Region, 2015-2021

    12.3. Current Market Size (US$ Bn) & Analysis and Forecast By Region, 2022-2032

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. Asia Pacific 

        12.3.5. Middle East and Africa (MEA)

    12.4. Market Attractiveness Analysis By Region

13. North America Point of Care Molecular Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2015-2021

    13.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2022-2032

        13.4.1. By Country

            13.4.1.1. U.S.

            13.4.1.2. Canada

            13.4.1.3. Rest of North America

        13.4.2. By Product & Service

        13.4.3. By Technology

        13.4.4. By End User

        13.4.5. By Application

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Product & Service

        13.5.3. By Technology

        13.5.4. By End User

        13.5.5. By Application

14. Latin America Point of Care Molecular Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2015-2021

    14.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2022-2032

        14.4.1. By Country

            14.4.1.1. Brazil

            14.4.1.2. Mexico

            14.4.1.3. Rest of Latin America

        14.4.2. By Product & Service

        14.4.3. By Technology

        14.4.4. By End User

        14.4.5. By Application

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Product & Service

        14.5.3. By Technology

        14.5.4. By End User

        14.5.5. By Application

15. Europe Point of Care Molecular Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2015-2021

    15.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2022-2032

        15.4.1. By Country

            15.4.1.1. Germany

            15.4.1.2. France

            15.4.1.3. U.K.

            15.4.1.4. Italy

            15.4.1.5. Benelux

            15.4.1.6. Nordic Countries

            15.4.1.7. Rest of Europe

        15.4.2. By Product & Service

        15.4.3. By Technology

        15.4.4. By End User

        15.4.5. By Application

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Product & Service

        15.5.3. By Technology

        15.5.4. By End User

        15.5.5. By Application

16. Asia Pacific Point of Care Molecular Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2015-2021

    16.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2022-2032

        16.4.1. By Country

            16.4.1.1. China

            16.4.1.2. Japan

            16.4.1.3. South Korea

            16.4.1.4. Rest of Asia Pacific

        16.4.2. By Product & Service

        16.4.3. By Technology

        16.4.4. By End User

        16.4.5. By Application

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Product & Service

        16.5.3. By Technology

        16.5.4. By End User

        16.5.5. By Application

17. Middle East and Africa Point of Care Molecular Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    17.1. Introduction

    17.2. Pricing Analysis

    17.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2015-2021

    17.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2022-2032

        17.4.1. By Country

            17.4.1.1. GCC Countries

            17.4.1.2. South Africa

            17.4.1.3. Turkey

            17.4.1.4. Rest of Middle East and Africa

        17.4.2. By Product & Service

        17.4.3. By Technology

        17.4.4. By End User

        17.4.5. By Application

    17.5. Market Attractiveness Analysis

        17.5.1. By Country

        17.5.2. By Product & Service

        17.5.3. By Technology

        17.5.4. By End User

        17.5.5. By Application

18. Key Countries Point of Care Molecular Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    18.1. Introduction

        18.1.1. Market Value Proportion Analysis, By Key Countries

        18.1.2. Global Vs. Country Growth Comparison

    18.2. US Point of Care Molecular Diagnostics Market Analysis

        18.2.1. Value Proportion Analysis by Market Taxonomy

        18.2.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.2.2.1. By Product & Service

            18.2.2.2. By Technology

            18.2.2.3. By End User

            18.2.2.4. By Application

    18.3. Canada Point of Care Molecular Diagnostics Market Analysis

        18.3.1. Value Proportion Analysis by Market Taxonomy

        18.3.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.3.2.1. By Product & Service

            18.3.2.2. By Technology

            18.3.2.3. By End User

            18.3.2.4. By Application

    18.4. Mexico Point of Care Molecular Diagnostics Market Analysis

        18.4.1. Value Proportion Analysis by Market Taxonomy

        18.4.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.4.2.1. By Product & Service

            18.4.2.2. By Technology

            18.4.2.3. By End User

            18.4.2.4. By Application

    18.5. Brazil Point of Care Molecular Diagnostics Market Analysis

        18.5.1. Value Proportion Analysis by Market Taxonomy

        18.5.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.5.2.1. By Product & Service

            18.5.2.2. By Technology

            18.5.2.3. By End User

            18.5.2.4. By Application

    18.6. Germany Point of Care Molecular Diagnostics Market Analysis

        18.6.1. Value Proportion Analysis by Market Taxonomy

        18.6.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.6.2.1. By Product & Service

            18.6.2.2. By Technology

            18.6.2.3. By End User

            18.6.2.4. By Application

    18.7. France Point of Care Molecular Diagnostics Market Analysis

        18.7.1. Value Proportion Analysis by Market Taxonomy

        18.7.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.7.2.1. By Product & Service

            18.7.2.2. By Technology

            18.7.2.3. By End User

            18.7.2.4. By Application

    18.8. Italy Point of Care Molecular Diagnostics Market Analysis

        18.8.1. Value Proportion Analysis by Market Taxonomy

        18.8.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.8.2.1. By Product & Service

            18.8.2.2. By Technology

            18.8.2.3. By End User

            18.8.2.4. By Application

    18.9. BENELUX Point of Care Molecular Diagnostics Market Analysis

        18.9.1. Value Proportion Analysis by Market Taxonomy

        18.9.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.9.2.1. By Product & Service

            18.9.2.2. By Technology

            18.9.2.3. By End User

            18.9.2.4. By Application

    18.10. UK Point of Care Molecular Diagnostics Market Analysis

        18.10.1. Value Proportion Analysis by Market Taxonomy

        18.10.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.10.2.1. By Product & Service

            18.10.2.2. By Technology

            18.10.2.3. By End User

            18.10.2.4. By Application

    18.11. Nordic Countries Point of Care Molecular Diagnostics Market Analysis

        18.11.1. Value Proportion Analysis by Market Taxonomy

        18.11.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.11.2.1. By Product & Service

            18.11.2.2. By Technology

            18.11.2.3. By End User

            18.11.2.4. By Application

    18.12. China Point of Care Molecular Diagnostics Market Analysis

        18.12.1. Value Proportion Analysis by Market Taxonomy

        18.12.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.12.2.1. By Product & Service

            18.12.2.2. By Technology

            18.12.2.3. By End User

            18.12.2.4. By Application

    18.13. Japan Point of Care Molecular Diagnostics Market Analysis

        18.13.1. Value Proportion Analysis by Market Taxonomy

        18.13.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.13.2.1. By Product & Service

            18.13.2.2. By Technology

            18.13.2.3. By End User

            18.13.2.4. By Application

    18.14. South Korea Point of Care Molecular Diagnostics Market Analysis

        18.14.1. Value Proportion Analysis by Market Taxonomy

        18.14.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.14.2.1. By Product & Service

            18.14.2.2. By Technology

            18.14.2.3. By End User

            18.14.2.4. By Application

    18.15. GCC Countries Point of Care Molecular Diagnostics Market Analysis

        18.15.1. Value Proportion Analysis by Market Taxonomy

        18.15.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.15.2.1. By Product & Service

            18.15.2.2. By Technology

            18.15.2.3. By End User

            18.15.2.4. By Application

    18.16. South Africa Point of Care Molecular Diagnostics Market Analysis

        18.16.1. Value Proportion Analysis by Market Taxonomy

        18.16.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.16.2.1. By Product & Service

            18.16.2.2. By Technology

            18.16.2.3. By End User

            18.16.2.4. By Application

    18.17. Turkey Point of Care Molecular Diagnostics Market Analysis

        18.17.1. Value Proportion Analysis by Market Taxonomy

        18.17.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.17.2.1. By Product & Service

            18.17.2.2. By Technology

            18.17.2.3. By End User

            18.17.2.4. By Application

        18.17.3. Competition Landscape and Player Concentration in the Country

19. Market Structure Analysis

    19.1. Market Analysis by Tier of Companies 

    19.2. Market Concentration

    19.3. Market Share Analysis of Top Players

    19.4. Market Presence Analysis

        19.4.1. By Regional footprint of Players

        19.4.2. Product footprint by Players

20. Competition Analysis

    20.1. Competition Dashboard

    20.2. Competition Benchmarking

    20.3. Competition Deep Dive 

        20.3.1. Abbott Laboratories (US) 

            20.3.1.1. Overview

            20.3.1.2. Product Portfolio

            20.3.1.3. Sales Footprint

            20.3.1.4. Strategy Overview

        20.3.2. F.Hoffmann-La Roche Ltd. (Switzerland)

            20.3.2.1. Overview

            20.3.2.2. Product Portfolio

            20.3.2.3. Sales Footprint

            20.3.2.4. Strategy Overview

        20.3.3. bioMérieux SA (France)

            20.3.3.1. Overview

            20.3.3.2. Product Portfolio

            20.3.3.3. Sales Footprint

            20.3.3.4. Strategy Overview

        20.3.4. Danaher Corporation (US)

            20.3.4.1. Overview

            20.3.4.2. Product Portfolio

            20.3.4.3. Sales Footprint

            20.3.4.4. Strategy Overview

        20.3.5. Quidel Corporation (US)

            20.3.5.1. Overview

            20.3.5.2. Product Portfolio

            20.3.5.3. Sales Footprint

            20.3.5.4. Strategy Overview

        20.3.6. QIAGEN N.V. (Netherlands)

            20.3.6.1. Overview

            20.3.6.2. Product Portfolio

            20.3.6.3. Sales Footprint

            20.3.6.4. Strategy Overview

        20.3.7. Co-Diagnostics, Inc. (US)

            20.3.7.1. Overview

            20.3.7.2. Product Portfolio

            20.3.7.3. Sales Footprint

            20.3.7.4. Strategy Overview

        20.3.8. Biocartis NV (Belgium)

            20.3.8.1. Overview

            20.3.8.2. Product Portfolio

            20.3.8.3. Sales Footprint

            20.3.8.4. Strategy Overview

        20.3.9. Meridian Bioscience, Inc. (US)

            20.3.9.1. Overview

            20.3.9.2. Product Portfolio

            20.3.9.3. Sales Footprint

            20.3.9.4. Strategy Overview

        20.3.10. Thermo Fisher Scientific, Inc. (US)

            20.3.10.1. Overview

            20.3.10.2. Product Portfolio

            20.3.10.3. Sales Footprint

            20.3.10.4. Strategy Overview

21. Assumptions and Acronyms Used

22. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Point of Care Molecular Diagnostics Market Value (US$ Bn),By Product & Service, 2015 – 2021

Table 2: Global Point of Care Molecular Diagnostics Market Value (US$ Bn),By Product & Service, 2022 – 2032

Table 3: Global Point of Care Molecular Diagnostics Market Value (US$ Bn), By Technology, 2015 – 2021

Table 4: Global Point of Care Molecular Diagnostics Market Value (US$ Bn), By Technology, 2022 – 2032

Table 5: Global Point of Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2015 – 2021

Table 6: Global Point of Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2022 – 2032

Table 7: Global Point of Care Molecular Diagnostics Market Value (US$ Bn), By End User, 2015 – 2021

Table 8: Global Point of Care Molecular Diagnostics Market Value (US$ Bn), By End User, 2022 – 2032

Table 9: Global Point of Care Molecular Diagnostics Market, By Region, 2015 – 2021

Table 10: Global Point of Care Molecular Diagnostics Market, By Region, 2022 – 2032

Table 11: North America Point of Care Molecular Diagnostics Market Value (US$ Bn),By Product & Service, 2015 – 2021

Table 12: North America Point of Care Molecular Diagnostics Market Value (US$ Bn),By Product & Service, 2022 – 2032

Table 13: North America Point of Care Molecular Diagnostics Market Value (US$ Bn), By Technology, 2015 – 2021

Table 14: North America Point of Care Molecular Diagnostics Market Value (US$ Bn), By Technology, 2022 – 2032

Table 15: North America Point of Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2015 – 2021

Table 16: North America Point of Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2022 – 2032

Table 17: North America Point of Care Molecular Diagnostics Market Value (US$ Bn), By End User, 2015 – 2021

Table 18: North America Point of Care Molecular Diagnostics Market Value (US$ Bn), By End User, 2022 – 2032

Table 19: North America Point of Care Molecular Diagnostics Market, By Country, 2015 – 2021

Table 20: North America Point of Care Molecular Diagnostics Market, By Country, 2022 – 2032

Table 21: Latin America Point of Care Molecular Diagnostics Market Value (US$ Bn),By Product & Service, 2015 – 2021

Table 22: Latin America Point of Care Molecular Diagnostics Market Value (US$ Bn),By Product & Service, 2022 – 2032

Table 23: Latin America Point of Care Molecular Diagnostics Market Value (US$ Bn), By Technology, 2015 – 2021

Table 24: Latin America Point of Care Molecular Diagnostics Market Value (US$ Bn), By Technology, 2022 – 2032

Table 25: Latin America Point of Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2015 – 2021

Table 26: Latin America Point of Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2022 – 2032

Table 27: Latin America Point of Care Molecular Diagnostics Market Value (US$ Bn), By End User, 2015 – 2021

Table 28: Latin America Point of Care Molecular Diagnostics Market Value (US$ Bn), By End User, 2022 – 2032

Table 29: Latin America Point of Care Molecular Diagnostics Market, By Country, 2015 – 2021

Table 30: Latin America Point of Care Molecular Diagnostics Market, By Country, 2022 – 2032

Table 31: Europe Point of Care Molecular Diagnostics Market Value (US$ Bn),By Product & Service, 2015 – 2021

Table 32: Europe Point of Care Molecular Diagnostics Market Value (US$ Bn),By Product & Service, 2022 – 2032

Table 33: Europe Point of Care Molecular Diagnostics Market Value (US$ Bn), By Technology, 2015 – 2021

Table 34: Europe Point of Care Molecular Diagnostics Market Value (US$ Bn), By Technology, 2022 – 2032

Table 35: Europe Point of Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2015 – 2021

Table 36: Europe Point of Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2022 – 2032

Table 37: Europe Point of Care Molecular Diagnostics Market Value (US$ Bn), By End User, 2015 – 2021

Table 38: Europe Point of Care Molecular Diagnostics Market Value (US$ Bn), By End User, 2022 – 2032

Table 39: Europe Point of Care Molecular Diagnostics Market, By Country, 2015 – 2021

Table 40: Europe Point of Care Molecular Diagnostics Market, By Country, 2022 – 2032

Table 41: Asia Pacific Point of Care Molecular Diagnostics Market Value (US$ Bn),By Product & Service, 2015 – 2021

Table 42: Asia Pacific Point of Care Molecular Diagnostics Market Value (US$ Bn),By Product & Service, 2022 – 2032

Table 43: Asia Pacific Point of Care Molecular Diagnostics Market Value (US$ Bn), By Technology, 2015 – 2021

Table 44: Asia Pacific Point of Care Molecular Diagnostics Market Value (US$ Bn), By Technology, 2022 – 2032

Table 45: Asia Pacific Point of Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2015 – 2021

Table 46: Asia Pacific Point of Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2022 – 2032

Table 47: Asia Pacific Point of Care Molecular Diagnostics Market Value (US$ Bn), By End User, 2015 – 2021

Table 48: Asia Pacific Point of Care Molecular Diagnostics Market Value (US$ Bn), By End User, 2022 – 2032

Table 49: Asia Pacific Point of Care Molecular Diagnostics Market, By Country, 2015 – 2021

Table 50: Asia Pacific Point of Care Molecular Diagnostics Market, By Country, 2022 – 2032

Table 51: MEA Point of Care Molecular Diagnostics Market Value (US$ Bn),By Product & Service, 2015 – 2021

Table 52: MEA Point of Care Molecular Diagnostics Market Value (US$ Bn),By Product & Service, 2022 – 2032

Table 53: MEA Point of Care Molecular Diagnostics Market Value (US$ Bn), By Technology, 2015 – 2021

Table 54: MEA Point of Care Molecular Diagnostics Market Value (US$ Bn), By Technology, 2022 – 2032

Table 55: MEA Point of Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2015 – 2021

Table 56: MEA Point of Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2022 – 2032

Table 57: MEA Point of Care Molecular Diagnostics Market Value (US$ Bn), By End User, 2015 – 2021

Table 58: MEA Point of Care Molecular Diagnostics Market Value (US$ Bn), By End User, 2022 – 2032

Table 59: MEA Point of Care Molecular Diagnostics Market, By Country, 2015 – 2021

Table 60: MEA Point of Care Molecular Diagnostics Market, By Country, 2022 – 2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 1: Global Point of Care Molecular Diagnostics Market Value (US$ Bn) and Year-on-Year Growth, 2015-2032

Figure 2: Global Point of Care Molecular Diagnostics Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 3: Global Point of Care Molecular Diagnostics Market Share, By Product & Service, 2022 & 2032

Figure 4: Global Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Product & Service – 2022-2032

Figure 5: Global Point of Care Molecular Diagnostics Market Attractiveness Index, By Product & Service – 2022-2032

Figure 6: Global Point of Care Molecular Diagnostics Market Share, By Technology, 2022 & 2032

Figure 7: Global Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 8: Global Point of Care Molecular Diagnostics Market Attractiveness Index, By Technology – 2022-2032

Figure 9: Global Point of Care Molecular Diagnostics Market Share, By End User, 2022 & 2032

Figure 10: Global Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 11: Global Point of Care Molecular Diagnostics Market Attractiveness Index, By End User – 2022-2032

Figure 12: Global Point of Care Molecular Diagnostics Market Share, By Application, 2022 & 2032

Figure 13: Global Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 14: Global Point of Care Molecular Diagnostics Market Attractiveness Index, By Application – 2022-2032

Figure 15: Global Point of Care Molecular Diagnostics Market Share, By Region, 2022 & 2032

Figure 16: Global Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Region – 2022-2032

Figure 17: Global Point of Care Molecular Diagnostics Market Attractiveness Index, By Region – 2022-2032

Figure 18: North America Point of Care Molecular Diagnostics Market Value (US$ Bn) and Year-on-Year Growth, 2015-2032

Figure 19: North America Point of Care Molecular Diagnostics Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 20: North America Point of Care Molecular Diagnostics Market Share, By Product & Service, 2022 & 2032

Figure 21: North America Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Product & Service – 2022-2032

Figure 22: North America Point of Care Molecular Diagnostics Market Attractiveness Index, By Product & Service – 2022-2032

Figure 23: North America Point of Care Molecular Diagnostics Market Share, By Technology, 2022 & 2032

Figure 24: North America Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 25: North America Point of Care Molecular Diagnostics Market Attractiveness Index, By Technology – 2022-2032

Figure 26: North America Point of Care Molecular Diagnostics Market Share, By End User, 2022 & 2032

Figure 27: North America Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 28: North America Point of Care Molecular Diagnostics Market Attractiveness Index, By End User – 2022-2032

Figure 29: North America Point of Care Molecular Diagnostics Market Share, By Application, 2022 & 2032

Figure 30: North America Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 31: North America Point of Care Molecular Diagnostics Market Attractiveness Index, By Application – 2022-2032

Figure 32: North America Point of Care Molecular Diagnostics Market Share, By Country, 2022 & 2032

Figure 33: North America Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 34: North America Market Attractiveness Index, By Country – 2022-2032

Figure 35: Latin America Point of Care Molecular Diagnostics Market Value (US$ Bn) and Year-on-Year Growth, 2015-2032

Figure 36: Latin America Point of Care Molecular Diagnostics Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 37: Latin America Point of Care Molecular Diagnostics Market Share, By Product & Service, 2022 & 2032

Figure 38: Latin America Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Product & Service – 2022-2032

Figure 39: Latin America Point of Care Molecular Diagnostics Market Attractiveness Index, By Product & Service – 2022-2032

Figure 40: Latin America Point of Care Molecular Diagnostics Market Share, By Technology, 2022 & 2032

Figure 41: Latin America Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 42: Latin America Point of Care Molecular Diagnostics Market Attractiveness Index, By Technology – 2022-2032

Figure 43: Latin America Point of Care Molecular Diagnostics Market Share, By End User, 2022 & 2032

Figure 44: Latin America Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 45: Latin America Point of Care Molecular Diagnostics Market Attractiveness Index, By End User – 2022-2032

Figure 46: Latin America Point of Care Molecular Diagnostics Market Share, By Application, 2022 & 2032

Figure 47: Latin America Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 48: Latin America Point of Care Molecular Diagnostics Market Attractiveness Index, By Application – 2022-2032

Figure 49: Latin America Point of Care Molecular Diagnostics Market Share, By Country, 2022 & 2032

Figure 50: Latin America Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 51: Latin America Point of Care Molecular Diagnostics Market Attractiveness Index, By Country – 2022-2032

Figure 52: Europe Point of Care Molecular Diagnostics Market Value (US$ Bn) and Year-on-Year Growth, 2015-2032

Figure 53: Europe Point of Care Molecular Diagnostics Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 54: Europe Point of Care Molecular Diagnostics Market Share, By Product & Service, 2022 & 2032

Figure 55: Europe Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Product & Service – 2022-2032

Figure 56: Europe Point of Care Molecular Diagnostics Market Attractiveness Index, By Product & Service – 2022-2032

Figure 57: Europe Point of Care Molecular Diagnostics Market Share, By Technology, 2022 & 2032

Figure 58: Europe Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 59: Europe Point of Care Molecular Diagnostics Market Attractiveness Index, By Technology – 2022-2032

Figure 60: Europe Point of Care Molecular Diagnostics Market Share, By End User, 2022 & 2032

Figure 61: Europe Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 62: Europe Point of Care Molecular Diagnostics Market Attractiveness Index, By End User – 2022-2032

Figure 63: Europe Point of Care Molecular Diagnostics Market Share, By Application, 2022 & 2032

Figure 64: Europe Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 65: Europe Point of Care Molecular Diagnostics Market Attractiveness Index, By Application – 2022-2032

Figure 66: Europe Point of Care Molecular Diagnostics Market Share, By Country, 2022 & 2032

Figure 67: Europe Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 68: Europe Point of Care Molecular Diagnostics Market Attractiveness Index, By Country – 2022-2032

Figure 69: MEA Point of Care Molecular Diagnostics Market Value (US$ Bn) and Year-on-Year Growth, 2015-2032

Figure 70: MEA Point of Care Molecular Diagnostics Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 71: MEA Point of Care Molecular Diagnostics Market Share, By Product & Service, 2022 & 2032

Figure 72: MEA Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Product & Service – 2022-2032

Figure 73: MEA Point of Care Molecular Diagnostics Market Attractiveness Index, By Product & Service – 2022-2032

Figure 74: MEA Point of Care Molecular Diagnostics Market Share, By Technology, 2022 & 2032

Figure 75: MEA Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 76: MEA Point of Care Molecular Diagnostics Market Attractiveness Index, By Technology – 2022-2032

Figure 77: MEA Point of Care Molecular Diagnostics Market Share, By End User, 2022 & 2032

Figure 78: MEA Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 79: MEA Point of Care Molecular Diagnostics Market Attractiveness Index, By End User – 2022-2032

Figure 80: MEA Point of Care Molecular Diagnostics Market Share, By Application, 2022 & 2032

Figure 81: MEA Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 82: MEA Point of Care Molecular Diagnostics Market Attractiveness Index, By Application – 2022-2032

Figure 83: MEA Point of Care Molecular Diagnostics Market Share, By Country, 2022 & 2032

Figure 84: MEA Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 85: MEA Point of Care Molecular Diagnostics Market Attractiveness Index, By Country – 2022-2032

Figure 86: Asia Pacific Point of Care Molecular Diagnostics Market Value (US$ Bn) and Year-on-Year Growth, 2015-2032

Figure 87: Asia Pacific Point of Care Molecular Diagnostics Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 88: Asia Pacific Point of Care Molecular Diagnostics Market Share, By Product & Service, 2022 & 2032

Figure 89: Asia Pacific Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Product & Service – 2022-2032

Figure 90: Asia Pacific Point of Care Molecular Diagnostics Market Attractiveness Index, By Product & Service – 2022-2032

Figure 91: Asia Pacific Point of Care Molecular Diagnostics Market Share, By Technology, 2022 & 2032

Figure 92: Asia Pacific Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 93: Asia Pacific Point of Care Molecular Diagnostics Market Attractiveness Index, By Technology – 2022-2032

Figure 94: Asia Pacific Point of Care Molecular Diagnostics Market Share, By End User, 2022 & 2032

Figure 95: Asia Pacific Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 96: Asia Pacific Point of Care Molecular Diagnostics Market Attractiveness Index, By End User – 2022-2032

Figure 97: Asia Pacific Point of Care Molecular Diagnostics Market Share, By Application, 2022 & 2032

Figure 98: Asia Pacific Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 99: Asia Pacific Point of Care Molecular Diagnostics Market Attractiveness Index, By Application – 2022-2032

Figure 100: Asia Pacific Point of Care Molecular Diagnostics Market Share, By Country, 2022 & 2032

Figure 101: Asia Pacific Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 102: Asia Pacific Point of Care Molecular Diagnostics Market Attractiveness Index, By Country – 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Neuro-Auto-Immune Disease Diagnostics Market

Published : October 2017

Healthcare

Near-Patient Molecular Solutions Market

Published : November 2016

Healthcare

Viral Molecular Diagnostics Market

Published : January 1970

Google translate

Point-of-care Molecular Diagnostics Market